Translumina Therapeutics Private Limited (“Translumina”), a subsidiary of Integris
Medtech Limited (formerly known as Integris Health Private Limited) (“Integris
Medtech”), Incorporated in 2009.
Over the years, Translumina has evolved into the cardiovascular segment of Integris
Medtech through a focused build-partner-acquire strategy.
Focused on improving patient care, we support healthcare professionals in over 65
countries (as of June 30, 2025)